Xiaohang Yang

No ORCID on file · 4 papers in corpus · active 2020-2021

Study types

  • article 3
  • preprint 1

Condition tags

  • endometriosis 4
  • infertility 2
  • chronic_pelvic_pain 1
article 2021
Lipidomic Alterations and PPARα Activation Induced by Resveratrol Lead to Reduction in Lesion Size in Endometriosis Models
Oxidative medicine and cellular longevity ·doi:10.1155/2021/9979953

Endometriosis is an estrogen‐dependent chronic inflammatory disease that affects approximately 10% of women of reproductive age and up to 50% of women with infertility. The heterogeneity of the disease makes accurate diagnosis and treatment…

article 2021
The Exploration of Poor Ovarian Response–Related Risk Factors: A Potential Role of Growth Differentiation Factor 8 in Predicting Ovarian Response in IVF-ET Patient
Frontiers in endocrinology ·doi:10.3389/fendo.2021.708089

Controlled ovarian hyperstimulation (COH) is the most common therapeutic protocol to obtain a considerable number of oocytes in IVF-ET cycles. To date, the risk factors affecting COH outcomes remain elusive. Growth differentiation factor 8 …

article 2021
Transcriptome-Based Analysis Reveals Therapeutic Effects of Resveratrol on Endometriosis in aRat Model
Drug design, development and therapy ·doi:10.2147/dddt.s323790

INTRODUCTION: Endometriosis (EMs) is associated with severe chronic pelvic pain and infertility and the development of improved EMs treatment options is an ongoing focus. In this study, we investigated the effects of resveratrol on EMs and …

preprint 2020
The Lipid-related Effects of Resveratrol on Human Ectopic Endometrial Stromal Cells and a Rat Model of Endometriosis
·doi:10.21203/rs.3.rs-110546/v1